India’s pharmaceutical sector sustained its export momentum with a 7.4% year-on-year growth in May 2025, according to data released by the Ministry of Commerce and Industry. Exports of drugs and pharmaceuticals stood at $2.47 billion during the month, up from $2.31 billion in May 2024. This marks a significant improvement over the 2.4% growth recorded in May 2024 compared to May 2023.

In Rupee terms, the export value rose by 9.69%, reaching Rs. 21,090 crore, compared to Rs. 19,227 crore in the same month last year. The increase highlights the continued global demand for Indian pharmaceutical products, especially in key markets such as the US, Europe, and emerging economies.

On the import front, medicinal and pharmaceutical products witnessed a modest rise of 3.04%, with imports totalling $786.12 million in May 2025, up from $762.91 million in the previous year. In Rupee terms, imports grew by 5.26%, to Rs. 6,696.96 crore from Rs. 6,362.13 crore reported during the same period last year.

For the first two months of the fiscal year 2025-26, cumulative exports of pharmaceutical products reached $4.96 billion, registering a growth of 4.81% compared to $4.73 billion in the same period of the previous fiscal. In Rupee terms, exports rose 7.3% to Rs. 42,361 crore, from Rs. 39,481 crore in April-May 2024.

Cumulative imports for the two-month period also showed an upward trend, growing 6.1% to $1.53 billion from $1.45 billion last year. In Rupee terms, the growth was 8.6%, reaching Rs. 13,104 crore as against Rs. 12,066 crore in the year-ago period.

India’s pharmaceutical exports had recorded a 9.39% growth in the full financial year 2024-25, touching $30.47 billion, up from $27.85 billion in FY 2023-24. The previous fiscal had also seen a robust 9.67% rise from $25.39 billion in FY 2022-23, underlining the sector’s resilience and steady global market expansion.